Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat

American Journal of Pathology

Volumn 171, Issue 4, 2007, Pages 1334-1341

  Tam, Neville N C ^a,b   Leav, Irwin ^b   Ho, Shuk Mei ^a,b,c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Kettering Complex ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; CYCLOOXYGENASE 2; ESTRADIOL; MESSENGER RNA; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SEX HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; INFLAMMATION; LASER CAPTURE MICRODISSECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; RAT; STROMA CELL;

EID: 35348901265     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070199     Document Type: Article

References (47)

1. Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, Oberley LW, Yan T, Zhong W, Jiang X, Oberley TD: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000, 89:123-134
2. Oberley TD, Zhong W, Szweda LI, Oberley LW: Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000, 44:144-155
3. Fang FC: Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004, 2:820-832
4. Lambeth JD: NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004, 4:181-189
5. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD: Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 2002, 99:715-720
6. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, Quinn MT, Krenitsky K, Ardie KG, Lambeth JD, Hoidal JR: NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol 2003, 285:C353-C369
7. Nelson WG, De Marzo AM, Deweese TL, Isaacs WB: The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004, 172:S6-11
8. Funk CD: Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875
9. Hussain SP, Hofseth LJ, Harris CC: Radical causes of cancer. Nat Rev Cancer 2003, 3:276-285
10. Hussain T, Gupta S, Mukhtar H: Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 2003, 191:125-135
11. Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB: Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res 2001, 61:8617-8623
12. Klaunig JE, Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004, 44:239-267
13. Kawanishi S, Hiraku Y, Pinlaor S, Ma N: Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 2006, 387:365-372
14. Nakabeppu Y, Sakumi K, Sakamoto K, Tsuchimoto D, Tsuzuki T, Nakatsu Y: Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biol Chem 2006, 387:373-379
15. De Marzo AM, Marchi VL, Epstein JI, Nelson WG: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999, 155:1985-1992
16. Taplin ME, Ho SM: Clinical review 134: the endocrinology of prostate cancer. J Clin Endocrinol Metab 2001, 86:3467-3477
17. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B: Human prostate cancer risk factors. Cancer 2004, 101:2371-2490
18. Tam NN, Gao Y, Leung YK, Ho SM: Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 2003, 163:2513-2522
19. Tam NN, Ghatak S, Ho SM: Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. Prostate 2003, 55:1-8
20. Bosland MC, Ford H, Horton L: Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol. Carcinogenesis 1995, 16:1311-1317
21. Tam NN, Chung SS, Lee DT, Wong YC: Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Carcinogenesis 2000, 21:2183-2191
22. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D: Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988, 80:1045-1053
23. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM: Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 1997, 18:1505-1510
24. Thompson CJ, Tam NN, Joyce JM, Leav I, and Ho SM: Gene expression profiling of testosterone and estradiol-17β-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Endocrinology 2002, 143:2093-2105
25. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM: Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 2004, 164:2003-2012
26. Tam NN, Nyska A, Maronpot RR, Kissling G, Lomnitski L, Suttie A, Bakshi S, Bergman M, Grossman S, Ho SM: Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants. Prostate 2006, 66:57-69
27. Butcher RL, Collins WE, Fugo NW: Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology 1974, 94:1704-1708
28. Uchida K: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42:318-343
29. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:C1424-C1437
30. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007, 7:256-269
31. Ho SM: Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 2004, 91:491-503
32. Doré M, Chevalier S, Sirois J: Estrogen-dependent induction of cyclooxygenase-2 in the canine prostate in vivo. Vet Pathol 2005, 42:100-103
33. Hertrampf T, Schmidt S, Laudenbach-Leschowsky U, Seibel J, Diel P: Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens. Mol Cell Endocrinol 2005, 243:51-57
34. Harris MT, Feldberg RS, Lau KM, Lazarus NH, Cochrane DE: Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate 2000, 44:19-25
35. Grande M, Carlstrom K, Stege R, Pousette A, Faxen M: Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells. Prostate 2000, 45:232-237
36. Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL, Chang TS: The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 1995, 63:1101-1107
37. Tangbanluekal L, Robinette CL: Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats. Endocrinology 1993, 132:2407-2416
38. Gilleran JP, Putz O, DeJong M, DeJong S, Birch L, Pu Y, Huang L, Prins GS: The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology 2003, 144:2046-2054
39. Meli R, Raso GM, Gualillo O, Pacilio M, Di Carlo R: Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats. Life Sci 1997, 61:1395-1403
40. Bolander Jr FF: Prolactin activation of mammary nitric oxide synthase: molecular mechanisms. J Mol Endocrinol 2002, 28:45-51
41. Lee SH, Nishino M, Mazumdar T, Garcia GE, Galfione M, Lee FL, Lee CL, Liang A, Kim J, Feng L, Eissa NT, Lin SH, Yu-Lee LY: 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res 2005, 65:7984-7992
42. Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000, 67-73
43. McCormick ML, Oberley TD, Elwell JH, Oberley LW, Sun Y, Li JJ: Superoxide dismutase and catalase levels during estrogen-induced renal tumorigenesis, in renal tumors and their autonomous variants in the Syrian hamster. Carcinogenesis 1991, 12:977-983
44. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV: Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 2003, 100:3913-3918
45. Cavalieri EL, Devanesan P, Bosland MC, Badawi AF, Rogan EG: Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23:329-333
46. Hurh YJ, Chen ZH, Na HK, Han SY, Surh YJ: 2-Hydroxyestradiol induces oxidative DNA damage and apoptosis in human mammary epithelial cells. J Toxicol Environ Health A 2004, 67:1939-1953
47. Schwartsburd PM: Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev 2003, 22:95-102